Ontology highlight
ABSTRACT:
SUBMITTER: Yin WM
PROVIDER: S-EPMC7470800 | biostudies-literature | 2020 Jul
REPOSITORIES: biostudies-literature
Yin Wei-Min WM Li Yu-Wei YW Gu Yun-Qing YQ Luo Min M
Acta pharmacologica Sinica 20200512 7
Cancer immunotherapy is rapidly changing the paradigm of cancer care and treatment by evoking host immunity to kill cancer cells. As clinical approval of checkpoint inhibitors (e.g., ipilimumab and pembrolizumab) has been accelerated by a dramatic improvement of long-term survival in a small subset of patients compared to conventional chemotherapy, growing interesting research has focused on immunotherapy. However, majority of patients have not benefited from checkpoint therapies that only parti ...[more]